Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
The expression of ErbB2 and ErbB3 receptors was unaltered in schizophrenia.
|
28646138 |
2017 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
BEFREE |
To our knowledge, this is the first association study between ERBB3 and schizophrenia in the Caucasian population.
|
19995212 |
2009 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
PSYGENET |
To our knowledge, this is the first association study between ERBB3 and schizophrenia in the Caucasian population.
|
19995212 |
2009 |
Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
NRG1, ERBB3, and NGFR show expression changes during the years of greatest risk for the development of schizophrenia.
|
18470533 |
2008 |
Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
There is also growing evidence for abnormal expression of myelin-related genes in schizophrenia: Neuregulin (NRG1) is important for oligodendrocyte development and function, and altered expression of erbB3, one of the NRG1 receptors, has been shown in schizophrenia patients.
|
17485733 |
2008 |
Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
However, our failure to find genetic association suggests that the differential expression of ERBB3 in schizophrenia may be environmentally driven, or involve cis- or trans-acting genetic factors beyond the boundaries of the gene itself.
|
16958035 |
2007 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
PSYGENET |
However, our failure to find genetic association suggests that the differential expression of ERBB3 in schizophrenia may be environmentally driven, or involve cis- or trans-acting genetic factors beyond the boundaries of the gene itself.
|
16958035 |
2007 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
BEFREE |
The present study shows that ERBB3 does not play a major role in conferring susceptibility to schizophrenia in the Japanese population.
|
17275115 |
2007 |
Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
LHGDN |
However, our failure to find genetic association suggests that the differential expression of ERBB3 in schizophrenia may be environmentally driven, or involve cis- or trans-acting genetic factors beyond the boundaries of the gene itself.
|
16958035 |
2007 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
BEFREE |
RGS4 interacts with ErbB3 that acts as receptors for neuregulin 1 and these proteins may play a role in the pathogenesis of schizophrenia via glutamatergic dysfunction.
|
17092693 |
2007 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
PSYGENET |
The present study shows that ERBB3 does not play a major role in conferring susceptibility to schizophrenia in the Japanese population.
|
17275115 |
2007 |
Schizophrenia
|
0.390 |
Biomarker
|
disease |
BEFREE |
Among the most consistent changes in genes with robust expression were significant decreases in the expression of myelination-related genes MAG, PLLP (TM4SF11), PLP1, ERBB3 in subjects with schizophrenia.
|
15334603 |
2004 |
Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
BEFREE |
Recently, the gene that encodes neuregulin-1 (NRG1) has been identified as a potential susceptibility gene for schizophrenia, and defects in the expression of erbB3, one of the NRG1 receptors, have been shown to occur in the prefrontal cortex of schizophrenic patients, suggesting that NRG1-erbB signaling is involved in the pathogenesis of schizophrenia.
|
15162166 |
2004 |
Schizophrenia
|
0.390 |
AlteredExpression
|
disease |
LHGDN |
Recently, the gene that encodes neuregulin-1 (NRG1) has been identified as a potential susceptibility gene for schizophrenia, and defects in the expression of erbB3, one of the NRG1 receptors, have been shown to occur in the prefrontal cortex of schizophrenic patients, suggesting that NRG1-erbB signaling is involved in the pathogenesis of schizophrenia.
|
15162166 |
2004 |